@article{b5bca46980e84839b173c30ad70bd000,
title = "Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register",
keywords = "oligoarticular juvenile idiopathic arthritis, etanercept, adalimumab, response, anti-tumour necrosis factor, biologic therapy",
author = "Janneke Anink and Otten, {Marieke H.} and Prince, {Femke H. M.} and Hoppenreijs, {Esther P. A. H.} and Wulffraat, {Nico M.} and Swart, {Joost F.} and {ten Cate}, Rebecca and {van Rossum}, {Marion A. J.} and {van den Berg}, {J. Merlijn} and Dolman, {Koert M.} and Yvonne Koopman-Keemink and Wineke Armbrust and Sylvia Kamphuis and {van Pelt}, {Philomine A.} and Gorter, {Simone L.} and {van Suijlekom-Smit}, {Lisette W. A.}",
year = "2013",
month = apr,
doi = "10.1093/rheumatology/kes373",
language = "English",
volume = "52",
pages = "712--717",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "4",
}